Cash · 2018–2025

Beam Therapeutics cash

$295M+4.6% · FY2025

Beam Therapeutics (BEAM) reported $295M in cash for fiscal 2025, +4.6% year on year.

$148M2018$37.2M2019$162M2020$560M2021$233M2022$436M2023$282M2024$295M2025
Beam Therapeutics — Cash, 2018–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$295M+4.6%Open →
FY20242024-12-31$282M−35.3%Open →
FY20232023-12-31$436M+87.3%Open →
FY20222022-12-31$233M−58.4%Open →
FY20212021-12-31$560M+245.3%Open →
FY20202020-12-31$162M+335.7%Open →
FY20192019-12-31$37.2M−74.8%Open →
FY20182018-12-31$148M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +10.4%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Beam Therapeutics cash |url=https://companiesranked.com/en/company/beam-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Beam Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/beam-therapeutics/cash-on-hand

BibTeX

@misc{companiesranked-en-company-beam-therapeutics-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Beam Therapeutics cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/beam-therapeutics/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001193125-26-331541 · August 4, 2026

{{cite web |title=Beam Therapeutics cash — 10-Q (0001193125-26-331541) |url=https://www.sec.gov/Archives/edgar/data/1745999/000119312526331541/beam-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Beam Therapeutics overview